EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 52021M10418

Prior notification of a concentration (Case M. 10418 - EFMS/Goldman Sachs/Parexel) Candidate case for simplified procedure (Text with EEA relevance) 2021/C 417/09


OJ C 417, 14.10.2021, p. 30–31 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)



Official Journal of the European Union

C 417/30

Prior notification of a concentration

(Case M. 10418 - EFMS/Goldman Sachs/Parexel)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 417/09)


On 5 October 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).

This notification concerns the following undertakings:

EQT IX, controlled by EQT Fund Management S.à r.l. (‘EFMS’, Luxembourg);

The Goldman Sachs Group Inc. (‘Goldman Sachs’, USA);

Parexel International Corporation (‘Parexel’, USA), solely controlled by Parexel Investment Holdings, L.P., which in turn is solely controlled by funds advised by Pamplona Investment Partners, L.P.

EFMS and Goldman Sachs acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Paraxel.

The concentration is accomplished by way of purchase of assets.


The business activities of the undertakings concerned are:

Goldman Sachs is a global investment banking, securities and investment management firm,

EFMS is an EQT investment fund that seeks to make investments primarily in Europe, with a focus on Northern Europe,

Parexel carries out biopharmaceutical outsourcing services providing a comprehensive suite of Phase I to IV solutions to the world’s biopharmaceutical companies.


On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.


The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M. 10418 - EFMS/Goldman Sachs/Parexel

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:


Fax +32 22964301

Postal address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel


(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  OJ C 366, 14.12.2013, p. 5.